University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Translational Research Institute

RFA

Call for Pilot Awards to Address Opioid Addiction and Pain Management

Researchers are encouraged to apply for pilot study awards being offered for opioid addiction and pain management research. Funded by UAMS, one-year awards of $25,000 will be available for studies that can produce data to support applications for larger extramural awards. Letters of intent (LOI) are due Oct. 8, 2018, by noon. View the Letter of Intent cover page.

Multidisciplinary teams will be given priority.  Any UAMS faculty, including at Arkansas Children’s Hospital and Research Institute, and the Central Arkansas Veterans Healthcare System, are invited to apply. View the Request for Applications (RFA) LOI document.  

Frequently Asked Questions

Contact: Nia Indelicato, NLIndelicato@uams.edu, or 501-526-0363.

Key Dates:

  • RFA released: Sept 10
  • Letter of Intent due: Oct. 8, by noon
  • Full applications invited: Oct. 12
  • TRI/Biostatistics consultations: Oct. 15 – 26
  • Proof of IRB submission due: Oct. 29, by noon (include in application)
  • Application due: Oct. 29, by noon
  • Videos due: Nov. 5 
  • Awardees announcement: Dec. 10 
  • Start date: Jan. 1, 2019

New Pilot Awards Available for CTSA Inter-institutional Studies

The Western States Consortium, which includes the UAMS Translational Research Institute (TRI) and four other Clinical and Translational Science Award (CTSA) institutions, has issued the call to all faculty for pilot award applications.

The purpose of the pilot awards is to promote inter-institutional collaboration by funding innovative, translational research projects that involve two or more of the four Western States Consortium members. Awards of up to $25,000 will be provided by each participating institution.

In addition to TRI, the Western States Consortium members are the University of Kentucky, University of New Mexico, University of Kansas Medical Center, and University of Utah, all part of the national CTSA consortium supported by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).

Applications are due August 10, 2018, at 5 p.m. (CT). Each proposal’s lead principal investigator will submit one combined proposal via an online application system.

For additional details, view the Request for Applications (RFA) document.

If you have any questions, please contact Nia Indelicato at NLIndelicato@uams.edu or 501-614-2287.

Key Dates:

  • Application Release Date: June 15, 2018
  • IRB Submission Deadline: July 13, 2018
  • Application Deadline: Aug. 10, 2018, 5 p.m. Central Time
  • Notice of intent to fund at each CTSA: Aug. 24, 2018
  • Just-In-Time Period: Aug. 24, 2018 – Aug. 31, 2018
  • Submission to NIH for Prior Approval of Human Subjects: Sept. 21, 2018
  • Funding Cycle: Nov. 1, 2018, through Oct. 31, 2019